Sensitization of candida albicans biofilms to fluconazole by terpenoids of plant origin

Journal of General and Applied Microbiology

Volumn 60, Issue 5, 2014, Pages 163-168

  Doke, Sonali Kashinath ^a   Raut, Jayant Shankar ^a   Dhawale, Shashikant ^a   Karuppayil, Sankunny Mohan ^a  

^a SWAMI RAMANAND TEERTH MARATHWADA UNIVERSITY   (India)

Author keywords

Antifungal; Biofilm; Candida albicans; Chemosensitizer; Combination therapy; Drug resistance; Plant molecule; Terpenoid

Indexed keywords

CARVACROL; EUGENOL; FLUCONAZOLE; TERPENOID DERIVATIVE; THYMOL; 2,3-BIS(2-METHOXY-4-NITRO-5-SULFOPHENYL)-5-((PHENYLAMINO)CARBONYL)-2H-TETRAZOLIUM HYDROXIDE; ANTIFUNGAL AGENT; TERPENE; TETRAZOLIUM;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; GROWTH INHIBITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; CHEMISTRY; DRUG EFFECTS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL VIABILITY; PHYSIOLOGY; PLANT; PROCEDURES; STAINING;

CANDIDA; CANDIDA ALBICANS;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; DRUG SYNERGISM; FLUCONAZOLE; MICROBIAL VIABILITY; PLANTS; STAINING AND LABELING; TERPENES; TETRAZOLIUM SALTS;

EID: 84924810965     PISSN: 00221260     EISSN: 13498037     Source Type: Journal    
DOI: 10.2323/jgam.60.163     Document Type: Article

References (22)

1. Ahmad, A., Khan, A., Yousuf, S., Khan, L. A., and Manzoor, N. (2010) Proton translocating ATPase mediated fungicidal activity of eugenol and thymol. Fitoterapia, 81, 1157-1162.
2. Amber, K., Aijaz, A., Immaculata, X., Luqman, K. A., and Nikhat, M. (2010) Anticandidal effect of Ocimum sanctum essential oil and its synergy with fluconazole and ketoconazole. Phytomedicine, 17, 921-925.
3. Campbell, B. C., Chan, K. L., and Kim, J. H. (2012) Chemosensitization as a means to augment commercial antifungal agents. Front. Microbiol., 3, doi:10.3389/fmicb.2012.00079.
4. Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormic, T. et al. (2001) Biofilm formation by fungal pathogen Candida albicans: Development, architecture and drug resistance. J. Bacteriol., 183, 5385-5394.
5. Clinical and Laboratory Standards Institute (2002) Reference method for broth dilution antifungal susceptibility testing of yeast: Approved standard, CLSI Document M27-A2. Wayne, Pa.
6. Costerton, J. W., Stewart, P. S., and Greenberg, E. P. (1999) Bacterial biofilms: A common cause of persistent infections. Science, 284, 1318-1322.
7. Guo, N., Liu, J., Wu, X., Bi, X., Meng, R. et al. (2009) Antifungal activity of thymol against clinical isolates of fluconazole sensitive and resistant Candida albicans. J. Med. Microbiol., 58, 1074-1079.
8. Inouye, S., Takahashi, M., and Abe, S. (2009) Inhibitory activity of hydrosols, herbal teas and related essential oils against filament formation and the growth of Candida albicans. Jpn. J. Med. Mycol., 50, 243-251.
9. Johnson, M. D., MacDougall, C., Ostrosky-Zeichner, L., Perfect, J. R., and Rex, J. H. (2004) Combination antifungal therapy. Antimicrob. Agents Chemother., 48, 693-715.
10. Khan, M. S. A. and Ahmad, I. (2012) Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms. J. Antimicrob. Chemother., 67, 618-621.
11. LaFleur, M. D., Kumamoto, C. A., and Lewis, K. (2006) Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob. Agents Chemother., 50, 3839-3846.
12. Marcos-Arias, C., Eraso, E., Madariaga, L., and Quindos, G. (2011) In vitro activities of natural products against oral Candida isolates from denture wearers. BMC Compl. Alternat. Med., 11: 119.
13. Ramage, G., Martinez, J. P., and Lopez-Ribot, J. L. (2006) Candida biofilms on implanted biomaterials: A clinically significant problem. FEMS Yeast Res., 6, 979-986.
14. Rao, A., Zhang, Y., Muend, S., and Rao, R. (2010) Mechanism of antifungal activity of terpenoid phenols resembles calcium stress and inhibition of the TOR pathway. Antimicrob. Agents Chemo­ ther., 54, 5062-5069.
15. Raut, J. S. and Karuppayil, S. M. (2014) Bioprospecting of plant essential oils for medicinal uses. In Environment and Sustainable Development, ed. by Fulekar, M. H., Pathak, B., and Kale, R. K., Springer, India, pp. 59-76.
16. Raut, J. S., Shinde, R. B., Chauhan, N. M., and Karuppayil, S. M. (2013) Terpenoids of plant origin inhibits morphogenesis, adhesion and biofilm formation by Candida albicans. Biofouling, 29, 87-96.
17. Sardi, J. C. O., Scorzoni, L., Bernardi, T., Fusco-Almeida, A. M., and Mendes Giannini, M. J. S. (2013) Candida species: Current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J. Med. Microbiol., 62, 10-24.
18. Shinde, R. B., Rajput, S. B., Raut, J. S., and Karuppayil, S. M. (2013a) An in vitro repositioning study reveals antifungal potential of chloroquine to inhibit growth and morphogenesis in Candida albicans. J. Gen. Appl. Microbiol., 59, 167-170.
19. Shinde, R. B., Raut J. S., and Karuppayil, S. M. (2012) Biofilm formation by Candida albicans on various prosthetic materials and its fluconazole sensitivity: A kinetic study. Mycoscience, 53, 220-226.
20. Shinde, R. B., Raut, J. S., Chauhan N. M., and Karuppayil, S. M. (2013b) Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles. Braz. J. Infect. Dis., 17, 395-400.
21. Shreaz, S., Bhatia, R., Khan, N., Muralidhar, S., Basir, S. F. et al. (2011) Exposure of Candida to p-anisaldehyde inhibits its growth and ergosterol biosynthesis. J. Gen. Appl. Microbiol., 57, 129-136.
22. Wagner, H. and Ulrich-Merzenich, G. (2009) Synergy research: Approaching a new generation of phytopharmaceuticals. Phytomedicine, 16, 97-110.